Daily pill halts Alzheimer's in its tracks
"This is an unprecedented result in the treatment of Alzheimer’s disease," said Prof Claude Wilschik, leader if a British research team. The results of the Phase 2 study suggests that the new medication known as "rember" stops Alzheimer's by as much as 81%. The findings are being hailed as the biggest breakthrough in the batle against Alzeimer's in over a century.
Patients with the brain disorder had no significant decline in their mental function over a 19-month period.
‘We appear to be bringing the worst affected parts of the brain functionally back to life,’ said Dr Claude Wischik, who led the research.
It is the first time medication has been developed to target the ‘tangles’ in the brain that destroy nerve cells, leading to deteriorating memory.
The drug helps to disrupt this process, preventing the formation of new tangles and loosening those already created.
Last night the findings were hailed as the biggest breakthrough in the battle against Alzheimer’s since 1907.
Eventually the drug could be used to stop the disease in its early stages before symptoms have even appeared, it is hoped.
update: see also report from Sanjay Jha